Back Pain News and Research

Latest Back Pain News and Research

The Journal of Pain publishes results from Butrans Transdermal System Phase 3 clinical study

Butrans (Buprenorphine) Transdermal System CIII 20 mcg/hour provided significantly lower "average pain over the last 24 hours" scores compared to Butrans 5 mcg/hour when used in opioid-experienced patients with moderate-to-severe chronic low back pain, according to a pivotal Phase 3 clinical study published in the online, August issue of The Journal of Pain.

26 Sep 2011

EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.

23 Sep 2011

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

Celgene International Sàrl was notified today that the E.U. Committee for Medicinal Products for Human Use (CHMP), on behalf of the European Medicines Agency (EMA) has concluded an Article 20 review of REVLIMID and issued a positive opinion for the use of REVLIMID in combination with dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

23 Sep 2011

USF receives U.S. Department of Defense award for musculoskeletal research

The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.

23 Sep 2011

Gothenburg researcher advises patients with acute low back pain to stay active

Move if you have back pain, this is the advice of a researcher at the Sahlgrenska Academy, University of Gothenburg. Patients with acute low back pain who were advised to stay active despite the pain fared better than those who were told to adjust their activity in line with their pain.

21 Sep 2011

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.

19 Sep 2011

Viewing video affects preferences for treatment of low back pain

Viewing an evidence-based video provides support to patients with low back pain in making decisions about whether to undergo surgical versus non surgical treatment, reports a study in a recent issue of Spine.

16 Sep 2011

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Alexion Pharmaceuticals, Inc. today announced that the Company's study of eculizumab in a small group of 14 patients with severe and refractory generalized myasthenia gravis, an ultra-rare and debilitating form of generalized myasthenia gravis (gMG), showed a strong disease improvement signal.

15 Sep 2011

Zimmer receives clearance for pediatric use of Universal Clamp Spinal Fixation System

Zimmer Holdings, Inc. announced today that it has received an additional clearance for its proprietary Universal Clamp Spinal Fixation System. A first for the United States, the system is now indicated for treatment of idiopathic and neuromuscular scoliosis in patients eight years of age or older. The Universal Clamp Spinal Fixation System is used in conjunction with spinal fusion surgeries.

14 Sep 2011

First Edition: September 12, 2011

Today's health policy headlines include reports about the pressures faced by the 'super committee' as well as the latest on how states are doing with the implementation of the health law.

12 Sep 2011

IBN scientists harness ultrasmall peptides to repair spinal disc damage

New ultrasmall peptides that can be used as building blocks for a wide range of regenerative applications such as spinal disc replacement and cartilage repair have been developed by scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute. These peptides spontaneously assemble in water to form hydrogels, which resemble collagen, a major component of connective tissues found in cartilage, ligaments, tendons, bone and skin.

12 Sep 2011

Chronic pain gene discovered

Scientists have found the gene responsible for chronic pain. It said that this could lead to drugs for treating long-lasting back pain.

12 Sep 2011

AOI Medical receives ISO 13485 Certification and CE marking approval for two VCF devices

AOI Medical, Inc. has received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Ascendx Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF).

8 Sep 2011

New bone marrow-derived stem cell therapy can benefit patients with degenerative disc disease

Neurosurgery researchers at UC Davis Health System have used a new, leading-edge stem cell therapy to promote the growth of bone tissue following the removal of cervical discs -- the cushions between the bones in the neck -- to relieve chronic, debilitating pain.

7 Sep 2011

Penn researchers receive NIH grant to continue programs of Musculoskeletal disorders center

Researchers from the Perelman School of Medicine at the University of Pennsylvania have been awarded another five-year, $3.2 million grant from the National Institutes of Health (NIH) to continue the programs of the Penn Center for Musculoskeletal Disorders.

7 Sep 2011

Health care politics: Perry's stem cell controversy, presidential contenders and health law; Biden Medicare fact check

Texas Gov. Rick Perry, who recently underwent an experimental injection of his own adult stem cells to relieve back pain, pushed a bill through the Legislature in June that paves the way for a company co-owned by his doctor to become the first state-approved "bank" to store and cultivate such cells for medical treatment that fact illustrates two aspects of his record that are drawing increasing attention as he pursues the presidency: his enthusiasm for ideas that are sometimes outside the scientific mainstream and what critics view as his willingness to use the levers of state government to benefit friends and political benefactors.

3 Sep 2011

Increased fat mass linked to high-intensity back pain

Increased back pain among people who are overweight or obese is specifically related to increased body fat content, reports a study in the September 15 issue of Spine.

2 Sep 2011

New minimally invasive technique now a feasible option to treat scoliosis in teenagers

Minimally invasive surgery to treat scoliosis in teenagers is now a "feasible option," according to Vishal Sarwahi, MD, Director of Spine Deformity Surgery at Montefiore Medical Center.

31 Aug 2011

Health Canada approves Bayer's STAXYN for treatment of erectile dysfunction

Today, Bayer Inc. announced the Health Canada approval of STAXYN, the first orally disintegrating tablet for the treatment of erectile dysfunction (ED) that lasts up to eight hours.

29 Aug 2011

High job stress causes workers to increasingly seek help from health professionals

Job-related stress is catching up with the Canadians. A new study by Concordia University economists, published in BMC Public Health, has found that increased job stress causes workers to increasingly seek help from health professionals for physical, mental and emotional ailments linked to job stress.

26 Aug 2011

Back Pain News and Research

Latest Back Pain News and Research

The Journal of Pain publishes results from Butrans Transdermal System Phase 3 clinical study

EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

USF receives U.S. Department of Defense award for musculoskeletal research

Gothenburg researcher advises patients with acute low back pain to stay active

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Viewing video affects preferences for treatment of low back pain

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Zimmer receives clearance for pediatric use of Universal Clamp Spinal Fixation System

First Edition: September 12, 2011

IBN scientists harness ultrasmall peptides to repair spinal disc damage

Chronic pain gene discovered

AOI Medical receives ISO 13485 Certification and CE marking approval for two VCF devices

New bone marrow-derived stem cell therapy can benefit patients with degenerative disc disease

Penn researchers receive NIH grant to continue programs of Musculoskeletal disorders center

Health care politics: Perry's stem cell controversy, presidential contenders and health law; Biden Medicare fact check

Increased fat mass linked to high-intensity back pain

New minimally invasive technique now a feasible option to treat scoliosis in teenagers

Health Canada approves Bayer's STAXYN for treatment of erectile dysfunction

High job stress causes workers to increasingly seek help from health professionals

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Back Pain News and Research

Latest Back Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in